Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 4Liver Neoplasms 3Stomach Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Thromboembolism 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Liver Diseases 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Gastrointestinal Stromal Tumors 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Sorafenib 5lenvatinib 3sintilimab 2pembrolizumab 2halofantrine 2camrelizumab 2atezolizumab 2Immunotherapy 2Blood Specimen Collection 2Bevacizumab 2Antibodies 2trifluridine tipiracil drug combination 1trametinib 1toripalimab 1titanium silicide 1tislelizumab 1linifanib 1genexol-PM 1gadolinium ethoxybenzyl DTPA 1fluorocholine 1fisogatinib 1ficlatuzumab 1durvalumab 1bavituximab 1avelumab 1User-Centered Design 1Sunitinib 1Sufentanil 1Standard of Care 1Shadowing Technique, Histology 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Diseases × High-Energy Shock Waves × Gastrointestinal × Clear all
NCT03811431 2019-01-22

ConCLUDe

Iuliu Hatieganu University of Medicine and Pharmacy

Phase NA Unknown
138 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡